Cross-institution positioning
Apr 29, 2026Mixed positioning. 1 reducing across 1 comparable institution.
Source: Schedule 13 researchSee how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. 1 reducing across 1 comparable institution.
Source: Schedule 13 researchRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Latest classified evidence: Prospectus filing. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue -8.1% YoY; Net income -127.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 81% through its reported 52-week range; -3.2% over one year.
Source: Stored historical price seriesFiled Apr 29, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Rose Cindy H | MExercise or conversion of derivative · derivative | CEO buyout award | 88.2K | — | Direct | Sep 2, 2026 |
| Sep 1, 2026 | Rose Cindy H | FTax/price withholding or payment | Ordinary Shares | 41.5K | — | Direct | Sep 2, 2026 |
| Sep 1, 2026 | Rose Cindy H | MExercise or conversion of derivative | Ordinary Shares | 88.2K | — | Direct | Sep 2, 2026 |
| Jun 15, 2026 | Rose Cindy H | MExercise or conversion of derivative · derivative | CEO buyout award | 187.3K | — | Direct | Jun 16, 2026 |
| Jun 15, 2026 | Rose Cindy H | FTax/price withholding or payment | Ordinary Shares | 88.2K | — | Direct | Jun 16, 2026 |
| Jun 15, 2026 | Rose Cindy H | MExercise or conversion of derivative | Ordinary Shares | 187.3K | — | Direct | Jun 16, 2026 |
| May 21, 2026 | Agnefjall Hans Peter Henrik | POpen-market or private purchase | Ordinary Shares | 75.0K | — | Direct | May 22, 2026 |
| May 8, 2026 | Wilson Rosemary Joanne | AGrant, award, or other acquisition · derivative | Conditional Award of Shares (2026 EPSP) | 279.7K | — | Direct | May 12, 2026 |
| May 8, 2026 | Rose Cindy H | AGrant, award, or other acquisition · derivative | Conditional Award of Shares (2026 EPSP) | 460.1K | — | Direct | May 12, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | 13.6B GBP | -8.1% |
| Ended Dec 31, 2024 | 14.7B GBP | -0.7% |
| Ended Dec 31, 2023 | 14.8B GBP | +2.9% |
| Ended Dec 31, 2022 | 14.4B GBP | +12.7% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Mar 31, 2026 observed Apr 29, 2026 filed · 29d Schedule 13G amendment | Reported reduction | 53.8M -1.6M | 12.00% 0.00 pts | $3.15 | $3.49 | $4.96 |
| BlackRock CIK0002012383 | Dec 31, 2025 observed Jan 21, 2026 filed · 21d Schedule 13G amendment | Reported reduction | 55.4M -38.1M | 12.00% +3.30 pts | $4.55 | $4.57 | $4.96 |
| BlackRock CIK0002012383 | Mar 31, 2025 observed Apr 23, 2025 filed · 23d Schedule 13G amendment | Reported reduction | 93.6M -45.9M | 8.70% -4.20 pts | $8.20 | $7.65 | $4.96 |
Compare WPPGF with other securities showing similar institutional activity or recent accumulation across several tracked institutions.